These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2754720)

  • 1. Water-soluble third generation antitumor platinum complexes, [2,2-bis (aminomethyl)-1,3-propanediol-N,N']-[1,1-cyclobutanedicarboxylato (2-)-O,O']platinum(II) and [1,1-cyclobutanedicarboxylato(2-)-O,O'] [tetrahydro-4H-pyran-4,4-dimethanamine-N,N']platinum(II).
    Bitha P; Carvajal SG; Citarella RV; Child RG; Delos Santos EF; Dunne TS; Durr FE; Hlavka JJ; Lang SA; Lindsay HL
    J Med Chem; 1989 Aug; 32(8):2015-20. PubMed ID: 2754720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new family of water-soluble, third generation antitumor platinum complexes.
    Bitha P; Carvajal SG; Citarella RV; Delos Santos EF; Durr FE; Hlavka JJ; Lang SA; Lindsay HL; Thomas JP; Wallace RE
    J Med Chem; 1989 Sep; 32(9):2063-7. PubMed ID: 2671371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antitumor activity of a series of [2-substituted-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II) complexes.
    Kim DK; Kim G; Gam J; Cho YB; Kim HT; Tai JH; Kim KH; Hong WS; Park JG
    J Med Chem; 1994 May; 37(10):1471-85. PubMed ID: 8182706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of a new platinum complex, 2-aminomethyl-pyrrolidine (1, 1-cyclobutanedicarboxylato) platinum (II).
    Endoh K; Akamatsu K; Matsumoto T; Morikawa K; Honda M; Mitsui H; Koizumi M; Koizumi K; Matsuno T
    Anticancer Res; 1989; 9(4):987-91. PubMed ID: 2817826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of platinum complexes of 2-aminomethylpyrrolidine derivatives for use as carrier ligands and their antitumor activities.
    Morikawa K; Honda M; Endoh K; Matsumoto T; Akamatsu K; Mitsui H; Koizumi M
    Chem Pharm Bull (Tokyo); 1990 Apr; 38(4):930-5. PubMed ID: 2379286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K; Akamatsu K; Matsumoto T; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Anticancer Res; 1992; 12(1):49-58. PubMed ID: 1567181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reaction of (R)-(-)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)platinum( II) with guanosine.
    Itoh M; Murata H; Honda M; Watanabe Y; Ochi K
    Chem Pharm Bull (Tokyo); 1989 Oct; 37(10):2825-7. PubMed ID: 2611943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of nude mouse-grown human urothelial cancer to cis-diamminedichloroplatinum(II), diammine[1,1-cyclobutanedicarboxylato(2-)-O,O'-platinum], and mitoguazone dihydrochloride.
    Kyriazis AP; Yagoda A; Kyriazis AA; Fogh J
    Cancer Res; 1985 May; 45(5):2012-5. PubMed ID: 3886128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of nude mouse-grown adenocarcinomas of the human exocrine pancreas to cis-diamminedichloroplatinum(II), diammine[1,1-cyclobutanedicarboxylato(2-)-O,O'-platinum], and mitoguazone dihydrochloride.
    Kyriazis AP; Kyriazis AA; Yagoda A; Fogh J
    Cancer Res; 1985 Sep; 45(9):4354-9. PubMed ID: 3896479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (2,2'-Bipyridine-kappa2N,N')(1,1-cyclobutanedicarboxylato-kappa2O,O')palladium(II), (1,1-cyclobutanedicarboxylato-kappa2O,O')(1,10-phenanthroline-kappa2N,N')palladium(II) monohydrate and (1,1-cyclobutanedicarboxylato-kappa2O,O')(1,10-phenanthroline-kappa2N,N')palladium(II) dihydrate.
    Muranishi Y; Okabe N
    Acta Crystallogr C; 2004 Feb; 60(Pt 2):m47-50. PubMed ID: 14767110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antitumor activities of platinum complexes of unsymmetrical alicyclic diamines as carrier ligands.
    Morikawa K; Honda M; Endoh K; Matsumoto T; Akamatsu K; Mitsui H; Koizumi M
    J Pharm Sci; 1990 Aug; 79(8):750-3. PubMed ID: 2231341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine anti-tumor activity of new water soluble platinum(II) complexes with reduced toxicity.
    Talebian AH; Bensely D; Schein PS; Green D
    Anticancer Drug Des; 1990 Nov; 5(4):371-8. PubMed ID: 2291775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, structure and antitumor activity of a new water-soluble platinum complex, (1R,2R-cyclohexanediamine-N,N')[2-hydroxy-4-oxo-2-pentenoato(2-)-O2] platinum(II).
    Kawai H; Kitano Y; Mutoh M; Hata G
    Chem Pharm Bull (Tokyo); 1993 Feb; 41(2):357-61. PubMed ID: 8500201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cis-[(4R,5R)-4,5-bis(aminomethyl)-2,2-dimethyl-1,3-dioxolane-N,N']- (malonato-O,O')platinum(II), an anticancer agent.
    Cho SW; Cho Y; Kim DK; Shin W
    Acta Crystallogr C; 2000 Jun; 56(Pt 6):653-4. PubMed ID: 10902008
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
    Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
    J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperthermic enhancement of cell killing by five platinum complexes in human malignant melanoma cells grown as monolayer cultures and multicellular spheroids.
    Kubota N; Kakehi M; Inada T
    Int J Radiat Oncol Biol Phys; 1993 Feb; 25(3):491-7. PubMed ID: 8436528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.
    Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A
    J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel water-soluble heptaplatin analogue with improved antitumor activity and reduced toxicity.
    Liu W; Chen X; Ye Q; Xu Y; Xie C; Xie M; Chang Q; Lou L
    Inorg Chem; 2011 Jun; 50(12):5324-6. PubMed ID: 21598993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical antitumor activity of CI-973,[SP-4-3-(R)]-[1,1- cyclobutanedicarboxylato(2-)](2 methyl-1,4-butane-diamine-N,N')platinum.
    Kraker AJ; Moore CW; Roberts BJ; Leopold WR; Elliott WL
    Invest New Drugs; 1991 Feb; 9(1):1-7. PubMed ID: 2026477
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.